Methodological considerations in the design of tri...[Curr Control Trials Cardiovasc Med. 2005] - PubMed Result

SearchDatabase nameforSearch term

Advanced Search

Your browser version may not work well with NCBI's Web applications. More information here...

Display Show

All: 1

Review: 0

Click to change filter selection through MyNCBI.

1: Curr Control Trials Cardiovasc Med. 2005 Feb 3;6(1):1. Links

Methodological considerations in the design of trials for safety assessment of new drugs and chemical entities.

Cornel Pater, Hannover, Germany. drcornelpater@aol.com.

PMID: 15691384 [PubMed - as supplied by publisher]

PMCID: PMC549209

Related Articles

[New anxiolytic drugs: methodological issues] [Encephale. 1993]
ReviewMethodological and design issues in clinical trials of new neuroleptics: an overview. [Br J Psychiatry Suppl. 1993]
ReviewThe role of pharmacological profiling in safety assessment. [Regul Toxicol Pharmacol. 1990]
Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. [Stroke. 2003]
Drug discontinuations in the United Kingdom and the United States, 1964 to 1983: issues of safety. [Clin Pharmacol Ther. 1984]

|

Display Show